Naveen Pemmaraju: Delighted to serve as a speaker at the recent AML-ALL US Focus meeting
Naveen Pemmaraju shared on LinkedIn:
“I was delighted to serve as an invited faculty speaker at the recent AML-ALL US Focus meeting in San Diego on my expert area topic ‘BPDCN Highlights’.
Meetings like this alongside my fellow experts in their fields are inspiring , as it gives me the opportunity to join my fellow experts to learn together, to teach together and to catch up on the latest research updates. Thanks to Ryan Fitzpatrick and MD Education for hosting us!”
Source: Naveen Pemmaraju/LinkedIn
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network.
He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
